ROTOP is a worldwide leading company in the field of development, cGMP manufacturing, registration and commercialization of cold kits and radiopharmaceuticals for diagnostic imaging agents. Headquartered in Dresden, Germany, with more than 180 employees.
NEWS
First marketing authorization for RoTecPSMA®
We are thrilled to announce that RoTecPSMA® has been approved in the United Kingdom!
RoTecPSMA® is a technetium-99m cold kit for SPECT imaging of prostate cancer patients and the first PSMA-SPECT tracer approved in a European country. It marks a significant step forward in closing a gap in patient care, making advanced diagnostics more accessible for those affected by prostate cancer.
NEWS
Upcoming events
June 21-24, 2025 | SNMMI (New Orleans, Louisiana, USA)
Annual Meeting Society of Nuclear Medicine and Molecular Imaging
October 05-08, 2025 | EANM (Barcelona, Spain)
Annual Meeting European Association of Nuclear Medicine
Please contact our team to make an appointment: cdmo@rotop-pharmaka.com
Quality and reliability
Our products
Together with our customers and partners, we are developing cold kits and radiopharmaceuticals for the treatment of patients.
